ArticleEuropean heart journal. Cardiovascular pharmacotherapy2025

Extensive LDL-cholesterol lowering by PCSK9 inhibitor on the risk of venous thrombosis.

Shinya Goto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.